secwatch / observer
8-K/A filed August 4, 2023, 7:59 PM ET ticker TWST CIK 0001581280
other material confidence high sentiment negative materiality 0.60

Twist Bioscience Corp (TWST): restructuring charge — Twist Bioscience reports $12.7M restructuring costs, exceeding prior $9-11M estimate

Twist Bioscience Corp

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

Twist Bioscience Corp announced a restructuring with charges of $9 and $11 million affecting South San Francisco and Wilsonville, Oregon facilities (approximately 270 employees worldwide, representing approximately 25% of the Company's total workforce).

Type
restructuring
Charge
$9 and $11 million
Affected area
South San Francisco and Wilsonville, Oregon facilities
Headcount
approximately 270 employees worldwide, representing approximately 25% of the Company's total workforce
Exact text from the filing
Company expects it to be substantially completed by the end of fiscal year 2023. As disclosed in the Original Report, the Company expected to incur pre-tax charges of between $9 and $11 million, consisting of cash expenditures for employee severance and related benefit costs. The Company recognized cumulative pre-tax restructuring costs of approximately
View on SEC.gov

Browse all restructurings & charges →

Twist Bioscience Corp filing history →

Source: SEC EDGAR
accession 0001104659-23-087548
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.